Trial Profile
A randomized controlled trial of alogliptin for secondary prevention of ischemic stroke and TIA with diabetes mellitus
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 08 Aug 2012
Price :
$35
*
At a glance
- Drugs Alogliptin (Primary)
- Indications Diabetes mellitus; Stroke; Transient ischaemic attacks
- Focus Therapeutic Use
- 04 Aug 2012 Actual initiation date changed from 1 Oct 2012 to 1 Jun 2012 as reported by ClinicalTrials.gov.
- 13 Feb 2012 New trial record